$154.69
00.00%
Pre-Market: Jul 19, 6:41 PM EDT
15 minutes delayed
Comments
Loading...
Johnson & Johnson
JNJNYSE
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Johnson & Johnson (NYSE:JNJ) Stock, Analyst Ratings, Price Targets, Forecasts
Johnson & Johnson has a consensus price target of $170.77 based on the ratings of 22 analysts. The high is $215 issued by Cantor Fitzgerald on July 1, 2024. The low is $40 issued by Mizuho on June 7, 2023. The 3 most-recent analyst ratings were released by Goldman Sachs, TD Cowen, and RBC Capital on July 19, 2024, July 18, 2024, and July 18, 2024, respectively. With an average price target of $171.67 between Goldman Sachs, TD Cowen, and RBC Capital, there's an implied 10.97% upside for Johnson & Johnson from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Goldman Sachs
TD Cowen
RBC Capital
Morgan Stanley
Cantor Fitzgerald
1calculated from analyst ratings
Analyst Ratings for Johnson & Johnson
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 07/19/2024 | Buy Now | 0.2% | Goldman Sachs | Chris Shibutani | $160 → $155 | Maintains | Neutral | Get Alert |
| 07/18/2024 | Buy Now | 19.59% | TD Cowen | Joshua Jennings | $195 → $185 | Maintains | Buy | Get Alert |
| 07/18/2024 | Buy Now | 13.13% | RBC Capital | Shagun Singh | $175 → $175 | Reiterates | Outperform → Outperform | Get Alert |
| 07/18/2024 | Buy Now | 9.25% | Morgan Stanley | Terence Flynn | $167 → $169 | Maintains | Equal-Weight | Get Alert |
| 07/01/2024 | Buy Now | 38.99% | Cantor Fitzgerald | Louise Chen | $215 → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 06/25/2024 | Buy Now | 38.99% | Cantor Fitzgerald | Louise Chen | $215 → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 06/20/2024 | Buy Now | 38.99% | Cantor Fitzgerald | Louise Chen | $215 → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 06/17/2024 | Buy Now | 13.13% | RBC Capital | Shagun Singh | $175 → $175 | Reiterates | Outperform → Outperform | Get Alert |
| 06/04/2024 | Buy Now | 13.13% | RBC Capital | Shagun Singh | $175 → $175 | Reiterates | Outperform → Outperform | Get Alert |
| 05/22/2024 | Buy Now | 13.13% | RBC Capital | Shagun Singh | → $175 | Reiterates | Outperform → Outperform | Get Alert |
| 05/16/2024 | Buy Now | 13.13% | RBC Capital | Shagun Singh | → $175 | Reiterates | Outperform → Outperform | Get Alert |
| 05/06/2024 | Buy Now | 38.99% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 04/18/2024 | Buy Now | 9.9% | HSBC | Morten Herholdt | $169 → $170 | Upgrade | Hold → Buy | Get Alert |
| 04/17/2024 | Buy Now | 38.99% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 04/17/2024 | Buy Now | 7.96% | Morgan Stanley | Terence Flynn | $168 → $167 | Maintains | Equal-Weight | Get Alert |
| 04/17/2024 | Buy Now | 13.13% | RBC Capital | Shagun Singh | $181 → $175 | Maintains | Outperform | Get Alert |
| 04/17/2024 | Buy Now | 9.9% | B of A Securities | Geoff Meacham | $180 → $170 | Maintains | Neutral | Get Alert |
| 04/15/2024 | Buy Now | 38.99% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 03/13/2024 | Buy Now | 38.99% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 02/28/2024 | Buy Now | 17.01% | RBC Capital | Shagun Singh | → $181 | Reiterates | Outperform → Outperform | Get Alert |
| 02/20/2024 | Buy Now | 38.99% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 02/06/2024 | Buy Now | 38.99% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 01/24/2024 | Buy Now | 9.25% | Morgan Stanley | Terence Flynn | $170 → $169 | Maintains | Equal-Weight | Get Alert |
| 01/24/2024 | Buy Now | 38.99% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 01/24/2024 | Buy Now | 17.01% | RBC Capital | Shagun Singh | → $181 | Reiterates | Outperform → Outperform | Get Alert |
| 01/23/2024 | Buy Now | 38.99% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 01/09/2024 | Buy Now | 38.99% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 01/03/2024 | Buy Now | 13.13% | Raymond James | Jayson Bedford | $172 → $175 | Maintains | Outperform | Get Alert |
| 12/13/2023 | Buy Now | 5.37% | Wells Fargo | Larry Biegelsen | $170 → $163 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/06/2023 | Buy Now | 17.01% | RBC Capital | Shagun Singh | $178 → $181 | Maintains | Outperform | Get Alert |
| 12/01/2023 | Buy Now | 15.07% | RBC Capital | Shagun Singh | → $178 | Reiterates | Outperform → Outperform | Get Alert |
| 12/01/2023 | Buy Now | 16.36% | UBS | Danielle Antalffy | → $180 | Upgrade | Neutral → Buy | Get Alert |
| 11/20/2023 | Buy Now | 38.99% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 11/17/2023 | Buy Now | 38.99% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 10/23/2023 | Buy Now | 38.99% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 10/18/2023 | Buy Now | 10.54% | Morgan Stanley | Terence Flynn | $174 → $171 | Maintains | Equal-Weight | Get Alert |
| 10/18/2023 | Buy Now | 11.19% | Raymond James | Jayson Bedford | $179 → $172 | Maintains | Outperform | Get Alert |
| 10/18/2023 | Buy Now | 38.99% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 10/12/2023 | Buy Now | 4.73% | Barclays | Matt Miksic | $158 → $162 | Maintains | Equal-Weight | Get Alert |
| 10/11/2023 | Buy Now | 38.99% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 10/11/2023 | Buy Now | 12.48% | Morgan Stanley | Terence Flynn | $172 → $174 | Maintains | Equal-Weight | Get Alert |
| 10/09/2023 | Buy Now | 38.99% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 10/05/2023 | Buy Now | 15.07% | RBC Capital | Shagun Singh | → $178 | Initiates | → Outperform | Get Alert |
| 10/02/2023 | Buy Now | 38.99% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 09/18/2023 | Buy Now | 38.99% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 09/08/2023 | Buy Now | 2.14% | Barclays | Matt Miksic | $175 → $158 | Maintains | Equal-Weight | Get Alert |
| 09/06/2023 | Buy Now | 13.13% | HSBC | Morten Herholdt | → $175 | Initiates | → Hold | Get Alert |
| 09/05/2023 | Buy Now | 38.99% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 09/05/2023 | Buy Now | 15.72% | Raymond James | Jayson Bedford | $184 → $179 | Maintains | Outperform | Get Alert |
| 08/31/2023 | Buy Now | 20.24% | Wells Fargo | Larry Biegelsen | $195 → $186 | Maintains | Overweight | Get Alert |
| 08/31/2023 | Buy Now | 38.99% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 08/31/2023 | Buy Now | 11.19% | Morgan Stanley | Terence Flynn | $187 → $172 | Maintains | Equal-Weight | Get Alert |
| 08/30/2023 | Buy Now | 38.99% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 08/22/2023 | Buy Now | 38.99% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 08/04/2023 | Buy Now | 9.9% | Atlantic Equities | Steve Chesney | $167 → $170 | Maintains | Neutral | Get Alert |
| 07/31/2023 | Buy Now | 38.99% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 07/25/2023 | Buy Now | 13.13% | Barclays | Matt Miksic | $171 → $175 | Maintains | Equal-Weight | Get Alert |
| 07/24/2023 | Buy Now | 18.95% | Raymond James | Jayson Bedford | $181 → $184 | Maintains | Outperform | Get Alert |
| 07/21/2023 | Buy Now | 16.36% | JP Morgan | Michael Weinstein | $175 → $180 | Maintains | Neutral | Get Alert |
| 07/21/2023 | Buy Now | 20.89% | Morgan Stanley | Terence Flynn | $187 → $187 | Reiterates | Equal-Weight → Equal-Weight | Get Alert |
| 07/21/2023 | Buy Now | 13.13% | Credit Suisse | Trung Huynh | $170 → $175 | Maintains | Neutral | Get Alert |
| 07/13/2023 | Buy Now | 38.99% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | Overweight → Overweight | Get Alert |
| 07/11/2023 | Buy Now | 20.89% | Morgan Stanley | Terence Flynn | $183 → $187 | Maintains | Equal-Weight | Get Alert |
| 06/07/2023 | Buy Now | -74.14% | Mizuho | Uy Ear | $36 → $40 | Maintains | Buy | Get Alert |
| 05/30/2023 | Buy Now | 19.59% | Citigroup | Joanne Wuensch | → $185 | Reinstates | → Buy | Get Alert |
| 04/19/2023 | Buy Now | 7.96% | Atlantic Equities | Steve Chesney | $168 → $167 | Maintains | Neutral | Get Alert |
| 04/19/2023 | Buy Now | 18.3% | Morgan Stanley | Terence Flynn | $179 → $183 | Maintains | Equal-Weight | Get Alert |
| 04/19/2023 | Buy Now | 17.01% | Raymond James | Jayson Bedford | $185 → $181 | Maintains | Outperform | Get Alert |
| 04/10/2023 | Buy Now | 15.72% | Morgan Stanley | Terence Flynn | $180 → $179 | Maintains | Equal-Weight | Get Alert |
| 03/29/2023 | Buy Now | 6.02% | UBS | Danielle Antalffy | → $164 | Initiates | → Neutral | Get Alert |
| 03/01/2023 | Buy Now | 4.08% | Guggenheim | Vamil Divan | → $161 | Initiates | → Neutral | Get Alert |
| 02/01/2023 | Buy Now | 38.99% | Cantor Fitzgerald | Louise Chen | → $215 | Reiterates | → Overweight | Get Alert |
| 01/25/2023 | Buy Now | 16.36% | Morgan Stanley | Terence Flynn | $176 → $180 | Maintains | Equal-Weight | Get Alert |
| 01/25/2023 | Buy Now | 8.6% | Atlantic Equities | Steve Chesney | $160 → $168 | Maintains | Neutral | Get Alert |
| 01/20/2023 | Buy Now | 20.24% | SVB Leerink | David Risinger | $194 → $186 | Maintains | Outperform | Get Alert |
| 12/12/2022 | Buy Now | 32.52% | Citigroup | Joanne Wuensch | $198 → $205 | Maintains | Buy | Get Alert |
| 12/06/2022 | Buy Now | 13.78% | Morgan Stanley | Terence Flynn | $178 → $176 | Maintains | Equal-Weight | Get Alert |
| 12/01/2022 | Buy Now | 15.07% | Morgan Stanley | Terence Flynn | $170 → $178 | Maintains | Equal-Weight | Get Alert |
| 11/18/2022 | Buy Now | 9.9% | Credit Suisse | Trung Huynh | → $170 | Initiates | → Neutral | Get Alert |
| 10/19/2022 | Buy Now | 9.9% | Morgan Stanley | Terence Flynn | $174 → $170 | Maintains | Equal-Weight | Get Alert |
| 10/19/2022 | Buy Now | 19.59% | Raymond James | Jayson Bedford | $192 → $185 | Maintains | Outperform | Get Alert |
| 10/19/2022 | Buy Now | 3.43% | Atlantic Equities | Steve Chesney | $165 → $160 | Maintains | Neutral | Get Alert |
| 10/18/2022 | Buy Now | 13.13% | Barclays | Matt Miksic | → $175 | Initiates | → Equal-Weight | Get Alert |
| 10/12/2022 | Buy Now | 12.48% | Morgan Stanley | Terence Flynn | $173 → $174 | Maintains | Equal-Weight | Get Alert |
| 09/12/2022 | Buy Now | 11.84% | Morgan Stanley | Terence Flynn | $174 → $173 | Maintains | Equal-Weight | Get Alert |
| 07/21/2022 | Buy Now | 16.36% | UBS | Kevin Caliendo | $185 → $180 | Maintains | Neutral | Get Alert |
| 07/20/2022 | Buy Now | 25.41% | SVB Leerink | David Risinger | $200 → $194 | Maintains | Outperform | Get Alert |
| 07/20/2022 | Buy Now | 6.66% | Atlantic Equities | Steve Chesney | $174 → $165 | Maintains | Neutral | Get Alert |
| 07/20/2022 | Buy Now | 24.12% | Raymond James | Jayson Bedford | $196 → $192 | Maintains | Outperform | Get Alert |
| 07/20/2022 | Buy Now | 29.94% | Citigroup | Joanne Wuensch | $205 → $201 | Maintains | Buy | Get Alert |
| 07/13/2022 | Buy Now | 26.06% | Wells Fargo | Larry Biegelsen | — | Maintains | Overweight | Get Alert |
| 07/08/2022 | Buy Now | 12.48% | Morgan Stanley | Terence Flynn | $173 → $174 | Maintains | Equal-Weight | Get Alert |
| 05/17/2022 | Buy Now | 32.52% | Citigroup | Joanne Wuensch | $210 → $205 | Maintains | Buy | Get Alert |
| 04/20/2022 | Buy Now | 35.76% | Citigroup | Joanne Wuensch | $203 → $210 | Maintains | Buy | Get Alert |
| 04/20/2022 | Buy Now | 26.71% | Raymond James | Jayson Bedford | $195 → $196 | Maintains | Outperform | Get Alert |
| 04/20/2022 | Buy Now | 32.52% | Credit Suisse | Matt Miksic | $200 → $205 | Maintains | Outperform | Get Alert |
| 04/14/2022 | Buy Now | 26.06% | Raymond James | Jayson Bedford | $185 → $195 | Maintains | Outperform | Get Alert |
| 04/12/2022 | Buy Now | 17.01% | Goldman Sachs | Chris Shibutani | $163 → $181 | Maintains | Neutral | Get Alert |
| 04/06/2022 | Buy Now | 11.84% | Morgan Stanley | Matthew Harrison | $175 → $173 | Maintains | Equal-Weight | Get Alert |
| 03/16/2022 | Buy Now | 18.3% | Bernstein | Lee Hambright | → $183 | Downgrade | Outperform → Market Perform | Get Alert |
FAQ
What is the target price for Johnson & Johnson (JNJ) stock?
The latest price target for Johnson & Johnson (NYSE:JNJ) was reported by Goldman Sachs on July 19, 2024. The analyst firm set a price target for $155.00 expecting JNJ to rise to within 12 months (a possible 0.20% upside). 58 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Johnson & Johnson (JNJ)?
The latest analyst rating for Johnson & Johnson (NYSE:JNJ) was provided by Goldman Sachs, and Johnson & Johnson maintained their neutral rating.
When was the last upgrade for Johnson & Johnson (JNJ)?
The last upgrade for Johnson & Johnson happened on April 18, 2024 when HSBC raised their price target to $170. HSBC previously had a hold for Johnson & Johnson.
When was the last downgrade for Johnson & Johnson (JNJ)?
The last downgrade for Johnson & Johnson happened on December 13, 2023 when Wells Fargo changed their price target from $170 to $163 for Johnson & Johnson.
When is the next analyst rating going to be posted or updated for Johnson & Johnson (JNJ)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Johnson & Johnson, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Johnson & Johnson was filed on July 19, 2024 so you should expect the next rating to be made available sometime around July 19, 2025.
Is the Analyst Rating Johnson & Johnson (JNJ) correct?
While ratings are subjective and will change, the latest Johnson & Johnson (JNJ) rating was a maintained with a price target of $160.00 to $155.00. The current price Johnson & Johnson (JNJ) is trading at is $154.69, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.